Notice Concerning Establishment Of Ono Global Reinsurance, Inc. As An Overseas Subsidiary (Specified Subsidiary)
01/08/2025 04:06
Aug 1 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T: ONO PHARMACEUTICAL CO LTD - NOTICE CONCERNING ESTABLISHMENT OF ONO GLOBAL REINSURANCE, INC. AS AN OVERSEAS SUBSIDIARY (SPECIFIED SUBSIDIARY) ONO PHARMACEUTICAL CO LTD - TO ESTABLISH WHOLLY-OWNED SUBSIDIARY IN HAWAII, U.S. WITH CAPITAL OF 10 BILLION YEN Source text: ID:nTSta809c5 Further company coverage: 4528.T
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours